You searched for: cancer
1 to 8 of 8 results
Show
results per page
Matched phrases in profile:
Using published datasets, and tissue donated by Brisbane breast cancer patients, we're trying to… Post-transcriptional regulation of the breast cancer susceptibility gene BRCA1 by Hu Antigen-R… Development of new theranostic agents for metastatic breast cancer surveillance and treatment… Molecular validation of autofluorescence and narrow band imaging of oral cancer resection margins… Most of the time, treatments for early breast cancer successfully prevent metastatic spread, but… Biomarkers of triple-negative breast cancer progression and response to therapy… cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research… BRCA1 is a breast cancer susceptibility gene that is down-regulated in the majority of cases of…
Dr Jodi Saunus is a senior fellow who specialises in translational research on metastatic breast cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to help facilitate patient-focused research at the interface of biomedical R&D and clinical pra …
Matched phrases in profile:
leads to diseases and cancer risk or progression. My current research is focused on developing… A potent antagonist of protease-activated receptor 2 that inhibits multiple signaling functions in human cancer cells… Therapeutics for inflammatory diseases and cancers… or pharmacology (animal models of inflammatory diseases, allergies & asthma, cancers… Experimental therapeutics for inflammatory diseases and cancers… , while inhibiting IL-6 secretion in PAR2 expressing MDA-MB-231 breast cancer cells. This research…
Junxian Lim is an accomplished molecular biologist at the Institute for Molecular Bioscience. With a strong background in cell biology, protein biochemistry, and pharmacology, he has established himself in the field. Collaborating with researchers at universities, institutions, as well as internatio …
Matched phrases in profile:
Can computers conceive the complexity of cancer to cure it? Using artificial intelligence technology in cancer modelling and drug discovery… Advancing Targeted Therapies for Metastatic Breast and Gynaecologic Cancers using RNA-based Therapeutics with Lipid Nanoparticle (LNP) Delivery System… BACKGROUND Cancer ranks as the second leading cause of death globally and Breast cancer (BC… Cancer Biology and Therapeutics… addressing cancer molecular mechanisms with the goal of developing novel cancer therapeutics and… , further complicated in the context of cancer research by the inherent heterogeneity and complexity of…
I am a Principal Investigator (PI) and a senior research officer (SRO) at Mater research – UQ with excellent clinical and research laboratory skills and expertise in conducting and analyzing laboratory assays and resolving complex research and clinical laboratory problems. I can describe myself as …
Matched phrases in profile:
Development of novel therapeutics for melanoma and non-melanoma cancer… Hypoxia-induced stress responses in cancer and cancer stem cells… Skin Cancer… ) promotes stress and death of the organism. However, cancer cells have evolved adaptive mechanisms to…
Researcher Biography
Dr Snehlata Kumari is the head of skin inflammation and immunity laboratory at the Frazer Institute, the University of Queensland in Brisbane, Australia. She is a board member of the Australasian Society for Dermatology Research (ASDR).
After PhD and post-doctoral training in …
Matched phrases in profile:
Cancers induce immunosuppressive mechanisms, and immunotherapy can either alleviate… early cancer detection and disease monitoring. These specific adaptive immune receptors are essential… Immunotherapy for persisting viral infection and associated cancer… Approaching antigen-presenting cell immunotherapy for cervical cancers using single-cell transcriptomics… health and in cancer. Dr. Tuong was born and raised in Singapore and moved to Brisbane… precancerous neoplasia that can eventuate in cervical cancer. Dendritic cells (DCs) are efficient in priming…
Dr. Kelvin Tuong is a Senior Research Fellow/Group Leader at the Ian Frazer Centre for Children’s Immunotherapy Research (IFCCIR), Child Health Research Centre. He is interested in single-cell analysis of immune cells and harnessing adaptive immune receptors for understanding immune cell development …
Matched phrases in profile:
selection in vaccine response; 3. Unraveling novel pathways sustaining T cell immunity in cancers… cancers by preventing a loss-of-function program termed 'exhaustion'. This research program has…
I am a Senior Research Fellow, NHMRC Emerging Leader Fellow, and Group Leader at UQ Frazer Institute. I was awarded my PhD in late 2017 by Biomedicine Discovery Institute, Monash University. Under the UQ Health Research Accelerator (HERA) program, I lead a team to investigate T and B cell responses …
Overall, I published 13x journal articles (6x 1st author or joint 1st author, 1x corresponding author) and 1x book chapter (1st author). The quality of my research in the field of T cell immunology was highlighted by three cutting-edge works published in Nature Immunology ( joint 1st author, 2021, s …
Matched phrases in profile:
Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles… . The procedure was done to treat ulcerative pancolitis complicated by colon cancer. She had a well…
Associate Professor Jakob Begun is the IBD Group leader in the Immunity, Infection, and Inflammation Program at Mater Research University of Queensalnd, and has a basic and translational laboratory at the Translational Research Institute in Brisbane. He is an Associate Professor in the University of …
Inflammatory bowel disease(IBD) is a complex disease with genetic and environmental triggers. The microbiota is one of the biggest environmental contributors and interest in its impact on human health and disease is a growing. Studies in IBD have led the way in identifying disease associated microbi …
Currently Helen works as a postdoctoral fellow at the Australian Institute for Bioengineering and Nanotechnology under Dr. Keith Chappell on a Rapid-Response Vaccine Pipeline to pressure-test the development of effective vaccines for priority human pathogens.
Helen received her Ph.D. in virology a …
1 to 8 of 8 results